Veracyte
VCYT
79 hedge funds and large institutions have $158M invested in Veracyte in 2017 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 31 increasing their positions, 20 reducing their positions, and 18 closing their positions.
55% more repeat investments, than reductions
Existing positions increased: 31 | Existing positions reduced: 20
50% more funds holding in top 10
Funds holding in top 10: 2 → 3 (+1)
1.41% more ownership
Funds ownership: 69.58% → 70.99% (+1.4%)
9% less funds holding
Funds holding: 87 → 79 (-8)
24% less capital invested
Capital invested by funds: $207M → $158M (-$49M)
44% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 18
95% less call options, than puts
Call options by funds: $48K | Put options by funds: $987K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
+$6.79M |
| 2 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
+$6.73M |
| 3 |
BlackRock
New York
|
+$4.34M |
| 4 |
First Manhattan
New York
|
+$2.03M |
| 5 |
CC
Cannell Capital
Alta,
Wyoming
|
+$1.85M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CAM
Cortina Asset Management
Milwaukee,
Wisconsin
|
-$6.03M |
| 2 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$4.6M |
| 3 |
AI
Axiom Investors
Greenwich,
Connecticut
|
-$3.41M |
| 4 |
BC
Broadfin Capital
New York
|
-$2.04M |
| 5 |
IBT
International Biotechnology Trust
London,
United Kingdom
|
-$1.49M |
VCYT Hedge Fund Activity: Q4 2017 in Review
79 of the 4,419 institutional investors tracked by Wall St. Rank reported a position in Veracyte (VCYT) for Q4 2017, worth a combined $158M — down 24% from $207M a quarter earlier.
Sellers outnumbered buyers: 18 funds closed out of VCYT and 10 opened new positions — a net loss of 8 holders — while 20 trimmed existing stakes and 31 added.
The largest buyer was ARK Investment Management, adding an estimated $6.79M. The largest seller was Cortina Asset Management, exiting entirely with an estimated $6.03M sold.
- 79 institutional investors held Veracyte (VCYT) as of Q4 2017, down from 87 in Q3 2017.
- Funds reported $158M of Veracyte stock for Q4 2017, down 24% quarter-over-quarter.
- 10 funds opened new Veracyte positions in Q4 2017 and 18 closed out, a net change of -8 holders.
- The largest Veracyte buyer in Q4 2017 was ARK Investment Management, an estimated $6.79M added.
- The largest Veracyte seller in Q4 2017 was Cortina Asset Management, an estimated $6.03M sold.
Based on aggregated 13F filings for Q4 2017.